Logo image of CHR-DB-C.CA

CHORUS AVIATION INC (CHR-DB-C.CA) Stock Overview

Canada - TSX:CHR-DB-C - CA17040TAG72

101.25 CAD
0 (0%)
Last: 10/9/2025, 7:00:00 PM
Fundamental Rating

4

Overall CHR-DB-C gets a fundamental rating of 4 out of 10. We evaluated CHR-DB-C against 7 industry peers in the Passenger Airlines industry. Both the profitability and the financial health of CHR-DB-C get a neutral evaluation. Nothing too spectacular is happening here. CHR-DB-C is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

CHR-DB-C had positive earnings in the past year.
CHR-DB-C had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CHR-DB-C reported negative net income in multiple years.
CHR-DB-C had a positive operating cash flow in each of the past 5 years.
CHR-DB-C.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR-DB-C.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

With a Return On Assets value of -1.91%, CHR-DB-C is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
The Return On Equity of CHR-DB-C (-4.82%) is comparable to the rest of the industry.
CHR-DB-C has a Return On Invested Capital of 6.54%. This is amongst the best in the industry. CHR-DB-C outperforms 85.71% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CHR-DB-C is in line with the industry average of 5.73%.
The 3 year average ROIC (5.30%) for CHR-DB-C is below the current ROIC(6.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROIC 6.54%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR-DB-C.CA Yearly ROA, ROE, ROICCHR-DB-C.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

CHR-DB-C has a Operating Margin (6.87%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CHR-DB-C has declined.
CHR-DB-C has a Gross Margin of 65.48%. This is amongst the best in the industry. CHR-DB-C outperforms 85.71% of its industry peers.
CHR-DB-C's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.87%
PM (TTM) N/A
GM 65.48%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR-DB-C.CA Yearly Profit, Operating, Gross MarginsCHR-DB-C.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR-DB-C is destroying value.
The number of shares outstanding for CHR-DB-C has been reduced compared to 1 year ago.
The number of shares outstanding for CHR-DB-C has been increased compared to 5 years ago.
Compared to 1 year ago, CHR-DB-C has an improved debt to assets ratio.
CHR-DB-C.CA Yearly Shares OutstandingCHR-DB-C.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR-DB-C.CA Yearly Total Debt VS Total AssetsCHR-DB-C.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 2.39 indicates that CHR-DB-C is not a great score, but indicates only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 2.39, CHR-DB-C belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
The Debt to FCF ratio of CHR-DB-C is 7.89, which is on the high side as it means it would take CHR-DB-C, 7.89 years of fcf income to pay off all of its debts.
CHR-DB-C's Debt to FCF ratio of 7.89 is amongst the best of the industry. CHR-DB-C outperforms 85.71% of its industry peers.
CHR-DB-C has a Debt/Equity ratio of 0.54. This is a neutral value indicating CHR-DB-C is somewhat dependend on debt financing.
CHR-DB-C has a better Debt to Equity ratio (0.54) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Altman-Z 2.39
ROIC/WACC0.76
WACC8.61%
CHR-DB-C.CA Yearly LT Debt VS Equity VS FCFCHR-DB-C.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.14 indicates that CHR-DB-C should not have too much problems paying its short term obligations.
CHR-DB-C has a Current ratio (1.14) which is comparable to the rest of the industry.
A Quick Ratio of 0.61 indicates that CHR-DB-C may have some problems paying its short term obligations.
CHR-DB-C has a worse Quick ratio (0.61) than 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.61
CHR-DB-C.CA Yearly Current Assets VS Current LiabilitesCHR-DB-C.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

CHR-DB-C shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.57%, which is quite impressive.
Measured over the past years, CHR-DB-C shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -19.03% on average per year.
The Revenue for CHR-DB-C has decreased by -13.36% in the past year. This is quite bad
The Revenue has been growing slightly by 0.56% on average over the past years.
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%

3.2 Future

CHR-DB-C is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.21% yearly.
CHR-DB-C is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.14% yearly.
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CHR-DB-C.CA Yearly Revenue VS EstimatesCHR-DB-C.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR-DB-C.CA Yearly EPS VS EstimatesCHR-DB-C.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 45.00 indicates a quite expensive valuation of CHR-DB-C.
Compared to the rest of the industry, the Price/Earnings ratio of CHR-DB-C is on the same level as its industry peers.
CHR-DB-C's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.34.
CHR-DB-C is valuated quite expensively with a Price/Forward Earnings ratio of 52.53.
The rest of the industry has a similar Price/Forward Earnings ratio as CHR-DB-C.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.86, CHR-DB-C is valued quite expensively.
Industry RankSector Rank
PE 45
Fwd PE 52.53
CHR-DB-C.CA Price Earnings VS Forward Price EarningsCHR-DB-C.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

71.43% of the companies in the same industry are cheaper than CHR-DB-C, based on the Enterprise Value to EBITDA ratio.
CHR-DB-C's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 53.21
EV/EBITDA 13.72
CHR-DB-C.CA Per share dataCHR-DB-C.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y12.98%
EPS Next 3Y1.21%

More info and screens

2

5. Dividend

5.1 Amount

CHR-DB-C has a Yearly Dividend Yield of 1.43%.
CHR-DB-C's Dividend Yield is a higher than the industry average which is at 2.43.
With a Dividend Yield of 1.43, CHR-DB-C pays less dividend than the S&P500 average, which is at 2.44.
Industry RankSector Rank
Dividend Yield 1.43%

5.2 History

The dividend of CHR-DB-C is nicely growing with an annual growth rate of 21.58%!
CHR-DB-C is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of CHR-DB-C are negative and hence is the payout ratio. CHR-DB-C will probably not be able to sustain this dividend level.
CHR-DB-C's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP-34.57%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
CHR-DB-C.CA Yearly Income VS Free CF VS DividendCHR-DB-C.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

More info and screens

CHORUS AVIATION INC

TSX:CHR-DB-C (10/9/2025, 7:00:00 PM)

101.25

0 (0%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners3.2%
Inst Owner ChangeN/A
Ins Owners1.35%
Ins Owner ChangeN/A
Market Cap2.59B
Analysts78
Price Target141.6 (39.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.43%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-34.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.45%
Min EPS beat(2)3.87%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)3.87%
Max EPS beat(4)207.96%
EPS beat(8)5
Avg EPS beat(8)11.1%
EPS beat(12)6
Avg EPS beat(12)4.98%
EPS beat(16)8
Avg EPS beat(16)3.11%
Revenue beat(2)0
Avg Revenue beat(2)-6.13%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-3.95%
Revenue beat(4)0
Avg Revenue beat(4)-6%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)2
Avg Revenue beat(8)-4.58%
Revenue beat(12)4
Avg Revenue beat(12)-2.85%
Revenue beat(16)7
Avg Revenue beat(16)0.11%
PT rev (1m)2.6%
PT rev (3m)2.6%
EPS NQ rev (1m)-0.35%
EPS NQ rev (3m)-5.64%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.29%
Revenue NQ rev (1m)-0.89%
Revenue NQ rev (3m)-2.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE 45
Fwd PE 52.53
P/S 1.89
P/FCF 53.21
P/OCF 30.64
P/B 4.82
P/tB 4.9
EV/EBITDA 13.72
EPS(TTM)2.25
EY2.22%
EPS(NY)1.93
Fwd EY1.9%
FCF(TTM)1.9
FCFY1.88%
OCF(TTM)3.3
OCFY3.26%
SpS53.45
BVpS20.99
TBVpS20.65
PEG (NY)0.81
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROCE 8.82%
ROIC 6.54%
ROICexc 6.9%
ROICexgc 6.96%
OM 6.87%
PM (TTM) N/A
GM 65.48%
FCFM 3.56%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexcg growth 3Y33.52%
ROICexcg growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Debt/EBITDA 1.36
Cap/Depr 30.21%
Cap/Sales 2.62%
Interest Coverage 2.06
Cash Conversion 39.75%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.61
Altman-Z 2.39
F-Score5
WACC8.61%
ROIC/WACC0.76
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A
EBIT growth 1Y-53.02%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year86.18%
EBIT Next 3Y12.53%
EBIT Next 5YN/A
FCF growth 1Y-79.47%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-70.44%
OCF growth 3Y12.73%
OCF growth 5Y0.25%